Manufacturing the next generation of biomaterials
Headquarters London, England, United Kingdom
Modern Synthesis is a London-based biomaterial startup that crafts progressive biomaterials and tangible material solutions for the fashion industry. While increasingly natural and biobased alternatives to synthetic materials are becoming available, most current alternatives either fail to meet the industry demand in aesthetics, performance, and cost or still rely on the use of harsh chemicals and synthetic binders. However, Modern Synthesis’ patent-pending “microbial weaving” process is poised to overcome these historical limitations. Their proprietary process employs bacteria to grow a strong, lightweight cellulose-based composite material that is naturally biodegradable and offers unique potential for aesthetic and performance customizations. While the materials’ strength and durability are comparable to that of natural and synthetic leather, the process requires a fraction of greenhouse gases, water, and land usage.
- Raised over $5.5M to date from Collaborative Fund, Petri Bio, Agfunder, AceCap and others
- CEO is an award winning designer, previously working on global material initiatives at adidas
- Modern Synthesis is working with leading global brands to help them transition away from animal and petrochemical derived materials
Currently Operating in One Region
More Ventures in Energy & Environment
Get the Unreasonable Newsletter
Get twice-monthly updates on Modern Synthesis and over 350 other ventures working to solve the world's toughest problems.
Must select the list to subscribe to.